GlassScriptPhysician profile
Dayker Fernandez
NPI 1225859523
$2,706.72
in general payments reported to CMS, 2019-2025
18 companies · $2,707 in 2025
The $2,707 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,706.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $675.30 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $391.44 | 2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $278.24 | 2025 | Rybelsus, Ozempic, Wegovy |
| Renalytix Ai, INC. | $265.98 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Bayer Healthcare Pharmaceuticals INC. | $212.57 | 2025 | |
| Merz North America, INC. | $190.64 | 2025 | |
| Glaxosmithkline, LLC. | $155.55 | 2025 | Trelegy Ellipta, Shingrix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $124.20 | 2025 | Caplyta |
| Alkermes, INC. | $122.23 | 2025 | Aristada, Lybalvi |
| Aimmune Therapeutics, INC. | $80.79 | 2025 | Zenpep |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.69 | 2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $40.57 | 2025 | |
| Pfizer INC. | $23.78 | 2025 | |
| Merck Sharp & Dohme LLC | $23.22 | 2025 | Pifeltro, Capvaxive |
| Ardelyx, INC. | $22.69 | 2025 | Ibsrela |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $21.89 | 2025 | The Cologuard Plus Collection Kit |
| Lundbeck LLC | $19.70 | 2025 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $14.24 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dayker Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.